ACIXF logo

ACIXF Acarix AB (publ)

Other OTC · Medical - Devices · Healthcare

$0.03
+0.00 (+0.00%)

Acarix AB (publ) operates as a medical technology enterprise, specializing in the development of swift, AI-powered diagnostic tools designed to exclude coronary artery disease (CAD). These solutions are deployed both within Sweden and on an international scale. The company's principal product is the CADScor System, an innovative diagnostic support device intended for immediate patient assessment. …

Market Cap: $31.45Mwww.acarix.com

Price (90d)

No price history yet — the daily price refresh runs once a day.

Signal Score (90d)

100
100
Aug 13Aug 13

Quote

Day Range
$0.03 – $0.03
52-Week Range
$0.02 – $0.04
Volume
$100.0K
Market Cap
$31.45M
50-Day Avg
$0.03
200-Day Avg
$0.03
Prev Close
$0.03
Open
$0.03

Valuation & Ratios

P/E Ratio
-6.62
EPS
$-0.04
P/B Ratio
8.31
P/S Ratio
43.08
Debt/Equity
0.00
Current Ratio
4.08
Dividend Yield
+0.0%
Gross Margin
+37.5%

Returns & Efficiency

Return on Equity
Return on Assets
FCF Yield
EV/EBITDA

Revenue & Net Income (Annual)

Fiscal YearRevenueNet IncomeEPS
2025$7.34M$-47.97M$-0.04
2024$6.20M$-66.19M$-0.08
2023$6.24M$-77.84M$-0.16
2022$5.82M$-76.98M$-0.31
2021$3.76M$-51.73M$-0.33

Social Signal Score

50
5d
50
1 mentions
30d
50
1 mentions
60d
50
1 mentions
90d
50
1 mentions
news: 1

Earnings

Thu, Nov 5(in 3 months)

Estimates and results for ACIXF via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.

Valuation

ACIXFhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.

Mentions (1)

  • Newsseekingalpha.com·1d ago·Neutral

    Acarix AB (publ) (ACIXF) Q2 2026 Earnings Call Prepared Remarks Transcript Acarix AB (publ) (ACIXF) Q2 2026 Earnings Call Prepared Remarks Transcript

    View source ↗